Variables Influencing the Effectiveness of Creatine Supplementation as a Therapeutic Intervention for Sarcopenia
Darren G. Candow1* 
Scott C. Forbes2 
Philip D. Chilibeck3 
Stephen M. Cornish4 
Jose Antonio5 
Richard B. Kreider6- 1Faculty of Kinesiology and Health Studies, University of Regina, Regina, SK, Canada
- 2Department of Physical Education, Brandon University, Brandon, MB, Canada
- 3College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada
- 4Faculty of Kinesiology and Recreation Management, University of Manitoba, Winnipeg, MB, Canada
- 5Department of Health and Human Performance, Nova Southeastern University, Davie, FL, United States
- 6Department of Health and Kinesiology, Texas A&M University, College Station, TX, United States
Sarcopenia is an age-related muscle condition characterized by a reduction in muscle quantity, force generating capacity and physical performance. Sarcopenia occurs in 8–13% of adults ≥ 60 years of age and can lead to disability, frailty, and various other diseases. Over the past few decades, several leading research groups have focused their efforts on developing strategies and recommendations for attenuating sarcopenia. One potential nutritional intervention for sarcopenia is creatine supplementation. However, research is inconsistent regarding the effectiveness of creatine on aging muscle. The purpose of this perspective paper is to: (1) propose possible reasons for the inconsistent responsiveness to creatine in aging adults, (2) discuss the potential mechanistic actions of creatine on muscle biology, (3) determine whether the timing of creatine supplementation influences aging muscle, (4) evaluate the evidence investigating the effects of creatine with other compounds (protein, conjugated linoleic acid) in aging adults, and (5) provide insight regarding the safety of creatine for aging adults.
Introduction
The original criteria for determining sarcopenia focused on muscle quantity (1); however, over the past few decades, numerous groups (International Working Group on Sarcopenia, Special Interest Group, European Working Group on Sarcopenia in Older People, Foundation for the National Institutes of Health, Asian Working Group on Sarcopenia, European Society of Clinical Nutrition and Metabolism, and International Sarcopenia Initiative) have expanded this criterion to include muscle strength and physical performance measures (2). Sarcopenia, now identified with an ICD-10-CM code by the World Health Organization (3) occurs in 8–13% of adults ≥ 60 years of age (4). The European Working Group on Sarcopenia in Older People classifies aging adults with low muscle strength (Grip strength test: <27 kg for males, <16 for females; Chair stand test: >15 s for five stands) as being pre-sarcopenic; those with low muscle strength and low muscle quantity (Appendicular skeletal muscle mass: <20 kg for males, <15 kg for females; Appendicular skeletal muscle mass/height2: <7.0 kg/m2 for males, <6.0 kg/m2 for females) as being sarcopenic, and those with low muscle strength, low muscle quantity and low physical performance (Gait speed: ≤0.8 m/s; Short Physical Performance Battery test: ≤ 8 point score; Timed Up-and Go test: ≥20 s; 400 m walk test: non-completion or ≥6 min for completion) as having severe sarcopenia (5). Sarcopenia is associated with disability, frailty, cachexia, morbidity, and various diseases (6, 7). Contributing factors of sarcopenia include changes in neuromuscular function, skeletal muscle morphology, protein kinetics, hormonal regulation, oxidative and inflammatory stress, physical inactivity, and nutrition [for reviews see (8, 9)].
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases [ESCEO; (10)] and International Conference on Sarcopenia and Frailty Research task force (11) recommends that nutritional interventions be emphasized to help overcome sarcopenia. We propose that creatine supplementation has the potential to be an anti-sarcopenic intervention. Three meta-analyses have been performed involving creatine supplementation and resistance training. In the first meta-analysis, Candow et al. (12) found a greater effect from creatine supplementation during resistance training on muscle mass (+0.94 kg) and upper-body maximal strength compared to placebo during resistance training in over 300 participants (>50 years of age). Expanding on these findings, Devries and Phillips (13) showed that creatine supplementation during resistance training resulted in greater gains in muscle mass (+1.33 kg) and upper- and lower-body maximal strength, and physical performance (30-s chair stand test) compared to placebo during training in over 200 aging adults (>45 years of age). In the most recent meta-analysis, Chilibeck et al. (14) showed that creatine supplementation during resistance training significantly increased muscle mass (+1.37 kg), and upper- and lower-body maximal strength compared to placebo during resistance training in over 700 aging adults (>57 years of age). Collectively, these meta-analyses indicate that the addition of creatine to resistance training significantly increases muscle mass (1.21 kg), maximum strength and has promise for improving tasks of physical performance in aging adults. However, variability in the responsiveness to creatine supplementation is typically high in aging adults and several factors determine whether an individual experiences greater gains in muscle mass and muscle/physical performance from creatine supplementation and resistance training. Therefore, the purpose of this perspective paper is to: (1) propose possible reasons for the inconsistent responsiveness to creatine in aging adults, (2) discuss the potential mechanistic actions of creatine on muscle biology, (3) determine whether the timing of creatine supplementation influences aging muscle, (4) evaluate the evidence investigating the effects of creatine with other compounds (protein, conjugated linoleic acid) in aging adults, and (5) provide insight regarding the safety of creatine for aging adults.
Creatine
Creatine (methylguanidine-acetic acid) is a naturally occurring nitrogenous organic acid (15). Ninety-five percent of creatine is stored in skeletal muscle while the remainder is found in brain, liver, kidneys, and testes (16). In skeletal muscle, approximately two-thirds of creatine is bound to phosphate and stored as phosphocreatine (PCr), the remaining one-third of creatine is unbound and stored as free creatine (15). An average 70-kg individual maintains a total creatine pool (PCr + free Cr = total creatine) of ~120 mmol/kg of dry muscle mass (17). Approximately 2 g/day (1–2%) of intramuscular creatine stores are broken down and excreted in the urine as creatinine (15). Both exogenous dietary intake and endogenous de novo synthesis are used to replace lost creatine. Dietary sources of creatine include meat, fish, and poultry with trace amounts in plants (18, 19). For example, one pound of uncooked salmon and beef contains about 2 g of creatine (18). Since plants only contain trace amounts, strict vegetarians and vegans typically have lower skeletal muscle total creatine stores (20). For most individuals, ~1–3 g/d of exogenous creatine intake are required to maintain creatine stores depending on total muscle mass and physical activity levels (17, 18, 21). Endogenous de novo creatine synthesis occurs in the liver and kidney (15, 18) via a two-step process. First, arginine and glycine form ornithine and guanidinoacetic acid (GAA) by the enzyme arginine glycine amidinotransferase (AGAT). Second, creatine is formed by the transfer of the methyl group from S-adenosyl methionine to guanidinoacetate (22), as shown in Figure 1.
Figure 1. Creatine is synthesized endogenously by a two step process from glycine, arginine, and methoione or through dietary intake. Ninety-five percent of creatine is taken up into the muscle and stored as free creatine (33%) or as phosphorylcreatine (67%). Approximately 2 g per day is broken down to creatinine and excreted.
Creatine Supplementation During Resistance Training in Aging Adults
There is a growing body of literature examining the effects of creatine supplementation and resistance training in aging adults (Table 1). Individual studies involving aging males or aging males and females combined show mixed results. However, studies only involving aging females show more consistent results. This section will summarize findings across studies and discuss possible methodological reasons for the conflicting results. Furthermore, variables influencing the responsiveness to creatine supplementation are also proposed.
Table 1. Resistance training and creatine studies in aging adults on performance and body composition changes.
While it is difficult to compare results across studies in aging males, differences in training methodologies may be involved. In the Candow et al. (30) and Chrusch et al. (31) studies (both showing a positive effect from creatine), participants were directly supervised during each training session. However, in the Cooke et al. (32) study, participants were only supervised during weeks 1, 2, 6, 8, and 11. Supervised resistance training leads to greater muscle benefits compared to unsupervised training (44). Furthermore, the sample sizes were larger in the Candow et al. (30) and Chrusch et al. (31) studies which increased statistical power compared to the Cooke et al. (32) study. The study by Eijnde et al. (33) incorporated both resistance and aerobic exercise components into the training intervention which introduces the possibility of muscle interference [i.e., blunting of muscle growth and performance when performing both resistance-training and aerobic exercise in the same training program; (45)]. In addition, the resistance training protocol focused on developing muscular endurance (20–30 repetition range) rather than muscular strength, a primary dependent measure assessed.
Five studies have investigated the effects of creatine supplementation during resistance training in aging females, as shown in Table 1. In postmenopausal osteopenic or osteoporotic females, Gualano et al. (26) showed that creatine supplementation during supervised resistance training produced greater gains (relative) in appendicular lean tissue mass (assessed by DXA) and upper-body (bench press) strength compared to placebo during resistance training. Previous work by Neves et al. (27) also found a beneficial effect from creatine on lower-limb lean tissue mass and indices of physical performance (timed-stand test) in postmenopausal women with knee osteoarthritis compared to placebo; however, there was no effect of creatine supplementation on total-body lean mass or muscle strength when compared to placebo. Additional work in postmenopausal women showed that creatine supplementation increased lean tissue mass, strength (bench press, knee extension, biceps curl), and tasks of physical performance (30-s chair stand, arm curl test, lying prone-to-stand test) compared to placebo (24). Chilibeck et al. (25) showed that postmenopausal females who ingested creatine daily during supervised whole-body resistance training experienced greater gains in relative upper-body maximal strength (bench press) compared to females on placebo. Finally, postmenopausal women who ingested creatine during a supervised strength training program had greater gains in lower-body (leg press) strength compared to females who ingested creatine or placebo but did not strength train. There were no differences between females who consumed creatine or placebo during training (23). Collectively, these results suggest that creatine supplementation during supervised resistance training is an effective lifestyle intervention for improving muscle mass and muscle/physical performance in aging postmenopausal women.
Research is limited regarding the effectiveness of creatine supplementation during resistance training in aging males and females combined, and therefore, there are only a few direct comparisons between males and females for responsiveness to creatine, as shown in Table 1. Brose et al. (36) showed that creatine supplementation increased lean tissue mass and isometric knee extension strength in aging adults compared to placebo. Males on creatine increased ankle-dorsiflexion isometric strength more than females on creatine. Candow et al. (37) and Pinto (42) found increases in strength and lean tissue mass with creatine and resistance training compared to placebo; however, no sex differences were found. Johannsmeyer et al. (41) showed that creatine supplementation increased whole-body lean tissue mass compared to placebo. Males on creatine increased upper-body strength (lat pull-down) and decreased urinary 3-methylhistidine excretion (indicator or whole-body protein catabolism) more than females on creatine. In contrast to these positive studies showing a beneficial effect from creatine, Bermon et al. (35) found no effect on strength or lean tissue mass. This study was limited by a small sample size (n = 8 per group) and a shorter training intervention (52 days) compared to the studies showing a positive effect from creatine (36, 37, 41, 42), and had participants perform a limited amount of work (3 exercises performed, 3 sets of 8 repetitions at 80% 1-RM). In two studies investigating disease populations, Deacon et al. (39) found no effect from creatine supplementation during 7 weeks of aerobic and resistance training on changes in muscle mass or performance in aging adults with chronic obstructive pulmonary disease (COPD) compared to those on placebo. In aging adults with type II diabetes, Gualano et al. (40) found no effect from creatine supplementation during 12 weeks of supervised aerobic and resistance combined training on muscle mass or strength compared to those on placebo. Both these disease state studies incorporated aerobic and resistance training into the exercise intervention which may have introduced the muscle interference effect (45). It is important to note that no sex analyses were performed in the studies of Bermon et al. (35), Deacon et al. (39), and Gualano et al. (40).
Methodological Differences Between Studies
Collectively, inconsistent results across studies (independent of sex), may be related to differences in the exercise training intervention (i.e., supervision vs. non-supervision; duration and volume of training; combination of aerobic and resistance training), health status and sample size.
Furthermore, variables which influence an individual's responsiveness to creatine supplementation should also be considered (46–48).
Variables Influencing Individual Responses to Creatine
(A) Baseline Muscle Creatine Content
The magnitude of response to creatine supplementation is typically determined by initial muscle creatine concentration (47), which can be quite variable in aging individuals and across one's lifespan. Aging adults typically have significantly lower PCr and total creatine compared to young adults (49–52), however one study reported no differences between older and younger participants (53). In contrast, Rawson et al. (54) showed that aging adults (n = 7) had higher resting PCr stores compared to younger adult (n = 8) in the gastrocnemius muscle. Chilibeck et al. (14) performed a meta-analysis to assess PCr differences between young and aging adults. Results showed that when the quadriceps, gastrocnemius, and tibialis anterior muscle groups were combined, there were no differences in muscle PCr across age groups. However, when only studies that assessed the quadriceps were included, there was an age-related reduction in intramuscular PCr, suggesting that muscle groups may respond differently.
(B) Muscle Fiber Type Differences
The majority of intramuscular creatine is found in type II muscle fibers (46) which progressively decreases (quantity, size) with aging [for review see Larsson et al. (8)). Syrotuik and Bell (48) showed that individuals with the highest concentration and muscle cross-sectional area of type II fibers respond more favorably to creatine supplementation. Therefore, the age-related reduction in type II muscle fiber quantity and size may potentially attenuate the anabolic response to creatine.
(C) Impact of Habitual Dietary Intake of Creatine
Dietary intake of creatine may also influence the responsiveness to supplementation. Individuals with low dietary consumption of creatine-containing foods [i.e., meat, seafood, poultry; (15, 19)] typically have low intramuscular creatine concentrations and would therefore respond more favorably to creatine supplementation. For example, Burke et al. (55) showed that vegetarians experienced the greatest increase in intramuscular total creatine (PCr, free Cr) from 8 weeks of creatine supplementation (0.25 g/kg lean tissue mass/day for 7 days + 0.0625 g/kg lean tissue mass/day for 49 days) compared to non-vegetarians who supplemented with creatine. Furthermore, in examining the effects of short-term creatine supplementation (0.3 g/day for 7 days) in omnivorous younger adults (n = 17, 29.18 ± 7.81 years) and aging individuals (n = 18, 71.78 ± 6.97 years), Solis et al. (52) showed that omnivores had higher dietary creatine intake pre-supplementation. Ingestion of creatine significantly increased PCr in aging individuals but not in the younger omnivore adults. There is evidence that meat consumption decreases with aging which may influence the response to creatine supplementation. We recommend that future research determine changes in intramuscular creatine concentration, type II muscle fiber quantity and size, and dietary intake of creatine so that a valid estimate regarding the effects of creatine supplementation in aging adults can be made.
Mechanisms by Which Creatine Supplementation Affects Muscle Mass in Aging Adults
Creatine supplementation may affect some of the mechanisms and pathways (those involving muscle protein synthesis and degradation) that contribute to sarcopenia (Figure 2). This section provides a review of mechanisms by which creatine may increase energy availability during resistance training, along with the effectiveness (or lack of effectiveness) of creatine supplementation for offsetting the effects of aging on muscle protein synthesis and degradation.
Figure 2. Potential mechanisms of creatine supplementation to enhance muscle hypertrophy and physical performance. IGF-1, insulin-like growth factor 1; MRFs, myogenic regulatory factors; mTOR, mammalian target of rapamycin; PCr, phosphorylcreatine; ROS, reactive oxygen species; SC, satellite cells.
Increased Training Volume and Muscle Contraction With Creatine Supplementation Through Increased Energy Provision and Calcium Uptake Into the Sarcoplasmic Reticulum
Phosphocreatine (PCr) is important for buffering ATP levels during intense muscle contraction (i.e., resistance training). ATP, which is broken down to ADP and inorganic phosphate (Pi) during muscle contraction, can be quickly re-synthesized when PCr donates its phosphate to ADP (15). Low intramuscular PCr levels may not be able to sustain continued muscle contractions during resistance training. Aging adults have reduced intramuscular PCr levels in the upper-leg (vastus lateralis); whereas PCr levels are at normal levels in muscles of the lower-leg (gastrocnemius, tibialis anterior), those involved in low-intensity activities of daily living (i.e., walking) (14). Potentially, the reduction in PCr in the vastus lateralis may be associated with reduced participation in high-intensity physical activities (i.e., running, jumping) which involve recruitment of large muscle groups in the lower-limbs (56). There is strong evidence from studies measuring creatine and PCr levels either through muscle biopsies or 31P-MRS that supplementation with creatine increases muscle creatine and/or PCr levels in muscle of aging adults (33, 36, 51, 52, 54). An animal model of senescence-accelerated mice indicated that creatine supplementation may lose its effectiveness over time due to down-regulation of the creatine transporter protein in muscle; however, this was not evident in aging humans (57).
Increased intramuscular PCr may provide greater capacity for ATP resynthesis during sustained intense muscular work or may enhance PCr recovery (i.e., and therefore greater recovery between sets of resistance training exercise) because an increase of creatine in the muscle would drive recovery of PCr through the reverse of the creatine kinase reaction (i.e., ATP + Cr → PCr + ADP) (51). Furthermore, creatine increases the rate of calcium uptake into the sarcoplasmic reticulum which may increase myofibrillar cross-bridge cycling leading to shortened muscle relaxation time and greater force development (58–60). Overall, this may lead to enhanced training volume during resistance training sessions in aging adults. In a study with full exercise supervision, where sets were performed with repetitions to failure, aging males (~70 years) were able to achieve a 31% greater training volume (defined as repetitions × kg) when supplemented with creatine compared to placebo during 12 weeks of resistance training (31). This has potential to stimulate greater training adaptations (i.e., greater increases in muscle mass and strength). This beneficial effect of creatine may not hold true however if resistance training is not performed to failure, which may be the case most of the time when older adults are performing resistance training non-supervised. Furthermore, in young participants, creatine supplementation was able to maintain resistance training volume and attenuate the interference effect of concurrent training (i.e., resistance and aerobic training) on strength adaptations (61). These results may have important implications in older adults, since both resistance and aerobic training are recommended and commonly practiced for optimal health.
Aside from PCr, glycogen is an important substrate that can drive re-phosphorylation of ATP during prolonged resistance training sessions, as evidenced by significant glycogen depletion during resistance training (62). Adults (> 50 years) with type II diabetes who supplemented with creatine (5 g/day) during 12 weeks exercise training (aerobic and resistance training, 3x/week) experienced a greater increase in membrane GLUT-4 content and membrane total GLUT-4 content ratio compared to adults on placebo (40). GLUT-4 is important for transport of glucose into muscle, and since glucose is a building block for glycogen, this has potential to enhance glycogen resynthesis following resistance training. Creatine supplementation in rats for 5 days before intermittent swimming spared gastrocnemius muscle glycogen when measured post-exercise (63). Blood lactate levels during exercise were also reduced with creatine supplementation suggesting that extra energy provided by phosphoryl creatine during the intermittent exercise resulted in a smaller requirement for anaerobic glycolysis, allowing sparing of glycogen. Potentially, the sparing of muscle glycogen would allow for greater exercise training capacity and volume to be performed leading to greater muscle mass and muscle/physical performance over time.
Aging and Pathways for Protein Synthesis—Effects of Creatine Supplementation
Resistance training increases the release of insulin-like growth factor-1 from muscle, which may stimulate activation of proteins called “myogenic regulatory factors” [MRFs; (64, 65)]. The MRFs are involved in activation, proliferation, and differentiation of satellite cells (66), which in turn are involved in muscle fiber repair/regeneration and thought to be important in the process of muscle hypertrophy (67). Satellite cells reside outside the muscle fiber between the sarcolemma and basal membrane and when activated they fuse with the muscle fiber membrane and cross the sarcolemma where they differentiate into myonuclei (67), which increases a muscle fiber's capacity for protein synthesis (68). Myostatin is a myokine (i.e., a hormone-like protein released from muscle) that has the opposite effect to MRFs and inhibits satellite cell activation (69). There is a reduction in satellite cell number with aging (70), and a reduced activation and proliferation of satellite cells in response to a session of resistance training (71). In young muscle, MRFs are increased and myostatin is reduced following a resistance training session, which leads to activation and proliferation of satellite cells (71). These responses are attenuated with aging (71). Although there is some evidence for creatine supplementation during resistance training to increase production of IGF-1, expression of MRFs, and activation of satellite cells in younger individuals (72–74), there is no evidence of this in aging adults. Males (55–70 years) had no increase (compared to placebo) in IGF-1 when supplemented with creatine (20 g/d for 5 days + 0.1 g/kg on training days thereafter) during 12 weeks of resistance training (32). In aging males (mean age 73 years) who supplemented with creatine (5 g/day) for 7 weeks, there was no greater increase in satellite cell's or expression of MRFs in response to resistance training compared to placebo (75). Furthermore, during surgical overload of the plantaris muscle in aging rats, creatine supplementation failed to affect myonuclear domain (i.e., the amount of myonuclei for a given muscle fiber area) and did not affect muscle fiber area compared to overload without creatine (76). This indicates unchanged satellite cell differentiation.
The pathway involving phosphatidylinositol 3-kinase [PI3K]-Akt/protein kinase B [PKB]-mammalian target of rapamycin [mTOR] is important for activation of translation within muscle and is therefore important for muscle protein synthesis in response to resistance training (77). Signaling through mTOR is reduced with aging (78) but there is no direct evidence that creatine supplementation influences mTOR in aging adults.
Aging and Pathways for Protein Degradation—Effects of Creatine Supplementation
In contrast to studies showing a lack of direct effect from creatine supplementation on mechanisms involved in protein synthesis, creatine supplementation may be effective for reducing muscle protein degradation. In younger males, but not females, acute supplementation with creatine (i.e., 20 g/day for 5 days followed by 5 g/day for 3–4 days) reduced leucine oxidation and the rate of appearance of leucine in blood after primed continuous intravenous infusion of radio-labeled leucine, indicating reduced protein degradation (79). This was accompanied by unchanged protein synthesis in both males and females (79). A global marker of muscle protein degradation, urinary 3-methylhistidine, is reduced in aging males (but not aging females) who supplemented with creatine during resistance training (30, 41). It is proposed that during the biological process of aging, there is damage to the mitochondria, causing defects in the respiratory chain, leading to production of reactive oxygen species (80). Reactive oxygen species can cause mutations in mitochondrial DNA (encoding for respiratory chain proteins) leading to further mitochondrial damage and a vicious cycle (80). Reactive oxygen species can damage cellular membranes, leading to inflammation, muscle damage, and muscle protein degradation. Supplementation with creatine may be effective in mitigating this mitochondrial damage, leading to reduced oxidative stress, inflammation, and cellular apoptosis (i.e., cell death). In cellular studies involving human umbilical vein endothelial cells (81) or skin cells (fibroblasts) (82), or mouse myoblasts (83) exposed to oxidative damage, incubation with creatine protected against mutations in mitochondrial DNA or mitochondrial damage. It was proposed that creatine is taken up by mitochondria, where it helps maintain energy status and function by transferring phosphate groups between sites of energy production (i.e., ATP) and sites of energy consumption (i.e., to re-phosphorylate ADP) (81). There is some support for creatine having a similar effect in aging adults. Compared to a placebo group, middle-aged males (mean age 48 years) who supplemented with 20 g/day of creatine for 7 days had reduced levels of proteolytic enzymes involved in apoptosis and DNA fragmentation, and upregulation of proteins involved in protection against mitochondrial damage after a muscle-damaging exercise session [i.e., 40 min of downhill running on a treadmill; ref. (84)]. In addition, aging males (mean age of 65 years) given a daily multi-ingredient nutritional supplement (containing 2.5 g of creatine) during 12 weeks of combined resistance and high-intensity interval training, had reduced levels of inflammation (as assessed by tumor necrosis factor- alpha and interleukin-6) compared to placebo (85). In this study, the nutritional supplement also contained calcium, vitamin D, and n-3 polyunsaturated fatty acids; therefore, the effects could not be attributed solely to the creatine. Finally, in an animal model of senescence-accelerated mice, a lifetime of creatine supplementation was effective at middle age (but not oldest age) for increasing muscle carnosine content (86). Carnosine has a number of protective mechanisms within muscle including prevention of glycosylation-induced protein damage, anti-oxidant effects, and pH buffering (86). Creatine supplementation was also effective at the middle-age mark for improving muscle function [i.e., attenuating fatigue in the slow-twitch soleus, and enhancing post-fatigue force recovery in fast-twitch extensor digitorum longus; (86)]. Future longer-term studies of creatine supplementation are needed to determine if there are similar benefits in older adults.
In summary, studies determining the mechanisms by which creatine supplementation may enhance muscle accretion in aging adults favor an effect from creatine on reducing muscle protein degradation, mainly through mitigation of mitochondrial damage.
Does the Timing of Creatine Ingestion Influence Aging Muscle?
It has been previously suggested that the strategic ingestion of creatine, in close proximity to resistance training, may help create a favorable environment for muscle growth (87). This section summarizes the limited body of research investigating the effects of the timing of creatine supplementation in response to resistance training.
In healthy aging adults who consumed creatine (0.1 g/kg) immediately before and cornstarch maltodextrin (0.1 g/kg) immediately after or cornstarch maltodextrin immediately before and creatine immediately after supervised whole-body resistance training sessions, significant improvements in upper-body (chest press) and lower-body (leg press) maximal strength were observed compared to placebo. There were no differences in strength gains between the creatine groups; however, only the group who consumed creatine post-exercise had statistically greater gains in lean tissue mass, compared to adults on placebo (37). Cribb and Hayes (88) found that a multi-ingredient supplement (including protein, carbohydrate, fat, and creatine monohydrate) in close proximity to training (i.e., immediately before and after) increased lean body mass and strength compared to ingesting the supplement in the morning and late evening (i.e., > 5 h from training) in young resistance trained participants. However, caution is warranted with a multi-ingredient study, since the impact of any individual nutrient is unknown. A small meta-analysis involving 3 studies (n = 80, > 18 years, ranging from 4 to 32 weeks) showed that post-exercise creatine supplementation led to greater gains in muscle mass compared to pre-exercise creatine [standardized mean difference 0.52, 95% CI 0.03–1.00, p = 0.04; (89)]. There were no differences between pre- and post-exercise creatine for effects on muscle strength. Loenneke et al. (90, 91) have recently provided evidence that exercise induced changes in muscle size do not contribute to exercise-induced changes in strength. Creatine has been shown to enhance training volume (24, 31), which is important for enhancing gains in muscle size, whereas training specificity seems to be more important for muscle strength (92). Although the mechanisms explaining the greater increase in muscle mass from post-exercise creatine remains to be determined, muscle contractions (during a resistance training session) stimulate creatine uptake into skeletal muscle, resulting in elevated intramuscular creatine stores (21). Greater intramuscular PCr is associated with greater muscle accretion in aging adults (36). Importantly, no study examining creatine timing has measured intramuscular creatine content, thus future research is warranted. Although the difference in muscle accumulation between pre- and post-exercise creatine is small, these results may be important for aging adults trying to maximize muscle accretion through the combination of creatine supplementation and resistance training.
Does the Combination of Creatine With Other Nutritional Supplements Augment Muscle Mass and Performance?
Research showing a beneficial effect from creatine, in combination with other nutritional supplements, is mixed. Aging males who supplemented with creatine (n = 10; 67.3 ± 3.1 years; 0.1 g/kg) and whey protein (0.3 g/kg) only on resistance-training days (3 days/week for 10 weeks) experienced greater gains in lean tissue mass (5.6 ± 0.9%), as measured by air-displacement plethysmography, and upper-body (bench press) strength compared to participants on creatine (n = 13, 65.5 ± 2.7 years; 2.2 ± 0.8%) or placebo (n = 12, 64.1 ± 3.1 years; 1.0 ± 1.0%) (30). However, in frail adults (n = 18, ≥65 years), the combination of creatine (5 g) and whey protein (20 g) during 12 weeks of resistance training failed to produce greater gains in lean tissue mass, handgrip strength, or indices of physical performance (time-up-and-go test, timed stand test) compared to whey protein alone (38). In aging males (48–72 years), the co-ingestion of creatine (5 g) and whey protein (35 g) during 14 weeks of resistance training increased whole-body lean tissue mass and measures of whole-body strength similarly to that of creatine or protein alone (28). Furthermore, Villanueva et al. (34) found no differences in muscle accretion, bench press strength, stair climbing power, or 400-m walk time from the combination of creatine (0.3 g/kg for 5 days + 0.07 g/kg for 68 days) and whey protein (35 g/day) during 12 weeks of resistance training compared to resistance training alone in aging males (68.1 ± 6.1 years). Results across individual studies suggest that the combination of creatine and protein does not provide additional muscle benefits compared to creatine or protein alone in aging adults.
The ingestion of a multi-ingredient supplement containing creatine (5 g), whey protein (60 g), vitamin D (1000 IU), EPA (2,800 mg), and DHA (1,780 mg) for 6 weeks significantly increased whole-body lean tissue mass (assessed by DXA), and upper-body strength in aging males (n = 25, 71 ± 1 years) compared to aging males on placebo (n = 24, 74 ± 1 years) (93). Interestingly, continued ingestion of the supplement during 12 weeks of supervised aerobic (1x/week) and resistance training (2x/week) did not lead to greater gains in lean tissue mass. Aging adults (n = 21, 65–85 years) who supplemented with creatine (5 g) and conjugated linoleic acid (CLA; 2 g) daily during 6 months of resistance training experienced greater gains in muscle accretion (2.1 kg) compared to those on placebo (n = 18; 0.9 kg increase) (43). The combination of creatine and CLA also increased lower-limb isokinetic strength and total-body muscle endurance (chest press, arm flexion, knee extension; females only). While it is difficult to determine whether creatine is responsible for the greater gains in muscle mass across individuals studies, a recent systematic review and meta-analysis performed by O'Bryan et al. (94) concluded that multi-ingredient supplements containing protein and creatine resulted in significantly greater gains in muscle mass compared to protein alone (1.01 kg; 95% CI [0.69, 1.33], p < 0.00001). Furthermore, Chilibeck et al. (14) showed that creatine supplementation during resistance training resulted in superior gains in muscle mass compared to placebo, even when studies involving protein and CLA were excluded from the meta-analysis.
Safety of Creatine Supplementation-Aging Adults and Clinical Populations
There is limited research regarding the safety profile of creatine supplementation. Self-reported adverse effects in aging adults from creatine include muscle cramping, muscle strains and gastrointestinal irritation. Using a retrospective questionnaire, Chrusch et al. (31) reported that 12 weeks of creatine supplementation (0.3 g/kg/day × 5 days + 0.07 g/kg/day thereafter) in aging males increased the incidence of muscle pulls and muscle strains compared to placebo. In aging adults (n = 11) who consumed creatine (0.3 g/kg) for 10 days, four adverse events were reports [pulled groin muscle, gastrointestinal irritation, constipation, bloating; (95)]. In aging postmenopausal women who ingested creatine (0.1 g/kg/day) during 52 weeks of resistance training, five participants reported symptoms of gastrointestinal irritation and two reported muscle cramping, which was higher (p < 0.05) than the adverse effects reported by females on placebo (25). However, several other studies indicate no adverse effects (self-reported) from creatine supplementation (23, 29, 37, 38).
There is no direct evidence that creatine supplementation causes cytotoxicity (urinary formaldehyde) in aging males (30) or has an adverse effect on kidney or liver function. Creatine supplementation (5 g/day) during 14 weeks of resistance training in frail adults resulted in no detrimental effect on kidney or liver function (38). In two studies involving aging post-menopausal females, creatine supplementation, with and without resistance training, had no effect on urinary albumin (96) or other markers of kidney (urea, microalbumin, urine protein, creatinine clearance) or liver function (bilirubin, aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase) (25). The co-ingestion of creatine and CLA during 6 months of resistance training had no effect on bilirubin or gamma glutamyltransferase protein in aging adults (43). From a clinical perspective, creatine supplementation did not alter kidney function (renal damage, hematuria, tubular damage, glomerular filtration rate, microalbumin) compared to placebo in aging patients with Parkinson Disease (97) or affect albuminuria, proteinuria, albumin: creatinine ratio, urea and creatinine and estimated creatinine clearance in aging adults with type II diabetes (40). In summary, self-reported adverse events from creatine supplementation include gastrointestinal issues and muscle pulls/strains. Direct assessment of kidney and liver function indicates no negative effect from creatine in aging adults.
Conclusions
Sarcopenia is an age-related muscle condition characterized by a reduction in muscle quantity, muscle performance (i.e., strength) and physical performance (i.e., tasks of functionality). Although multifactorial, sarcopenia may be caused by changes in muscle protein kinetics, neuromuscular function, inflammation, physical activity, and nutrition. Recent attention has focused on nutritional interventions as a potential therapeutic approach to counteract sarcopenia. When consumed during resistance training, creatine supplementation typically increases muscle mass and muscle/physical performance, possibly by influencing high-energy phosphate metabolism and calcium uptake, muscle protein kinetics, and inflammation. However, variability in the responsiveness to creatine supplementation is typically high in aging adults and factors such as initial intramuscular PCr concentration, type II muscle fiber content and size, and habitual dietary intake of creatine may possibly explain the inconsistent findings across individual studies. Furthermore, methodological issues such as sex, exercise training intervention, sample size, and participant health status may also influence study results.
Author Contributions
DC, SF, PC, SC, JA, and RK contributed to the design, methodology, evaluation, writing, edits, and approval of the submission.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. (1997) 127(5 Suppl.):991S. doi: 10.1093/jn/127.5.990S
2. Marty E, Liu Y, Samuel A, Or O, Lane J. A review of sarcopenia: enhancing awareness of an increasingly prevalent disease. Bone. (2017) 105:276–86. doi: 10.1016/j.bone.2017.09.008
3. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. (2016) 7:512–4. doi: 10.1002/jcsm.12147
4. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. (2017) 16:21. doi: 10.1186/s40200-017-0302-x
5. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. (2019) 48:16–31. doi: 10.1093/ageing/afy169
6. Ogawa S, Yakabe M, Akishita M. Age-related sarcopenia and its pathophysiological bases. Inflamm Regen. (2016) 36:5. doi: 10.1186/s41232-016-0022-5
7. Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. (2013) 93:101–20. doi: 10.1007/s00223-013-9758-y
8. Larsson L, Degens H, Li M, Salviati L, Lee YI, Thompson W, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. (2019) 99:427–511. doi: 10.1152/physrev.00061.2017
9. Liguori I, Russo G, Aran L, Bulli G, Curcio F, Della-Morte D, et al. Sarcopenia: assessment of disease burden and strategies to improve outcomes. Clin Interv Aging. (2018) 13:913–27. doi: 10.2147/CIA.S149232
10. Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, et al. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. (2018) 37:1121–32. doi: 10.1016/j.clnu.2017.08.016
11. Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. (2018) 22:1148–61. doi: 10.1007/s12603-018-1139-9
12. Candow DG, Chilibeck PD, Forbes SC. Creatine supplementation and aging musculoskeletal health. Endocrine. (2014) 45:354–61. doi: 10.1007/s12020-013-0070-4
13. Devries MC, Phillips SM. Creatine supplementation during resistance training in older adults-a meta-analysis. Med Sci Sports Exerc. (2014) 46:1194–203. doi: 10.1249/MSS.0000000000000220
14. Chilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med. (2017) 8:213–26. doi: 10.2147/OAJSM.S123529
15. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. (2000) 80:1107–213. doi: 10.1152/physrev.2000.80.3.1107
16. Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol. (1979) 50:177–242. doi: 10.1002/9780470122952.ch4
17. Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol. (1996) 81:232–37. doi: 10.1152/jappl.1996.81.1.232
18. Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. (1994) 18:268–80. doi: 10.2165/00007256-199418040-00005
19. Jung S, Bae YS, Kim HJ, Jayasena DD, Lee DD, Park HB, et al. Carnosine, anserine, creatine, and inosine 5'-monophosphate contents in breast and thigh meats from 5 lines of Korean native chicken. Poultry Sci. (2013) 92:3275–82. doi: 10.3382/ps.2013-03441
20. Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R, et al. International society of sports nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. (2017) 14:18. doi: 10.1186/s12970-017-0173-z
21. Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci. (1992) 83:367–74. doi: 10.1042/cs0830367
22. Paddon-Jones D, Borsheim E, Wolfe RR. Potential ergogenic effects of arginine and creatine supplementation. J Nutr. (2004) 134 (10 Suppl.):2894S; discussion 2895S. doi: 10.1093/jn/134.10.2888S
23. Alves CR, Merege Filho CA, Benatti FB, Brucki S, Pereira RM, de Sa Pinto AL, et al. Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind study. PLoS ONE. (2013) 8:e76301. doi: 10.1371/journal.pone.0076301
24. Aguiar AF, Januario RS, Junior RP, Gerage AM, Pina FL, do Nascimento MA, et al. Long-term creatine supplementation improves muscular performance during resistance training in older women. Eur J Appl Physiol. (2013) 113:987–96. doi: 10.1007/s00421-012-2514-6
25. Chilibeck PD, Candow DG, Landeryou T, Kaviani M, Paus-Jenssen L. Effects of creatine and resistance training on bone health in postmenopausal women. Med Sci Sports Exerc. (2015) 47:1587–95. doi: 10.1249/MSS.0000000000000571
26. Gualano B, Macedo AR, Alves CR, Roschel H, Benatti FB, Takayama L, et al. Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial. Exp Gerontol. (2014) 53:7–15. doi: 10.1016/j.exger.2014.02.003
27. Neves M, Gualano B, Roschel H, Fuller R, Benatti FB, Pinto AL, et al. Beneficial effect of creatine supplementation in knee osteoarthritis. Med Sci Sports Exerc. (2011) 43:1538–43. doi: 10.1249/MSS.0b013e3182118592
28. Bemben MG, Witten MS, Carter JM, Eliot KA, Knehans AW, Bemben DA. The effects of supplementation with creatine and protein on muscle strength following a traditional resistance training program in middle-aged and older men. J Nutr Health Aging. (2010) 14:155–9. doi: 10.1007/s12603-009-0124-8
29. Eliot KA, Knehans AW, Bemben DA, Witten MS, Carter J, Bemben MG. The effects of creatine and whey protein supplementation on body composition in men aged 48 to 72 years during resistance training. J Nutr Health Aging. (2008) 12:208–12. doi: 10.1007/BF02982622
30. Candow DG, Little JP, Chilibeck PD, Abeysekara S, Zello GA, Kazachkov M, et al. Low-dose creatine combined with protein during resistance training in older men. Med Sci Sports Exerc. (2008) 40:1645–52. doi: 10.1249/MSS.0b013e318176b310
31. Chrusch MJ, Chilibeck PD, Chad KE, Davison KS, Burke DG. Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc. (2001) 33:2111–7. doi: 10.1097/00005768-200112000-00021
32. Cooke MB, Brabham B, Buford TW, Shelmadine BD, McPheeters M, Hudson GM, et al. Creatine supplementation post-exercise does not enhance training-induced adaptations in middle to older aged males. Eur J Appl Physiol. (2014) 114:1321–32. doi: 10.1007/s00421-014-2866-1
33. Eijnde BO, Van Leemputte M, Goris M, Labarque V, Taes Y, Verbessem P, et al. Effects of creatine supplementation and exercise training on fitness in men 55-75 yr old. J Appl Physiol. (2003) 95:818–28. doi: 10.1152/japplphysiol.00891.2002
34. Villanueva MG, He J, Schroeder ET. Periodized resistance training with and without supplementation improve body composition and performance in older men. Eur J Appl Physiol. (2014) 114:891–905. doi: 10.1007/s00421-014-2821-1
35. Bermon S, Venembre P, Sachet C, Valour S, Dolisi C. Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. Acta Physiol Scand. (1998) 164:147–55. doi: 10.1046/j.1365-201X.1998.00427.x
36. Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci. (2003) 58:11–9. doi: 10.1093/gerona/58.1.B11
37. Candow DG, Vogt E, Johannsmeyer S, Forbes SC, Farthing JP. Strategic creatine supplementation and resistance training in healthy older adults. Appl Physiol Nutr Metab. (2015) 40:689–94. doi: 10.1139/apnm-2014-0498
38. Collins J, Longhurst G, Roschel H, Gualano B. Resistance training and co-supplementation with creatine and protein in older subjects with frailty. J Frailty Aging. (2016) 5:126–34. doi: 10.14283/jfa.2016.85
39. Deacon SJ, Vincent EE, Greenhaff PL, Fox J, Steiner MC, Singh SJ, et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2008) 178:233–9. doi: 10.1164/rccm.200710-1508OC
40. Gualano B, de Salles Painneli V, Roschel H, Artioli GG, Neves M, de Sa Pinto AL, et al. Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Med Sci Sports Exerc. (2011) 43:770–8. doi: 10.1249/MSS.0b013e3181fcee7d
41. Johannsmeyer S, Candow DG, Brahms CM, Michel D, Zello GA. Effect of creatine supplementation and drop-set resistance training in untrained aging adults. Exp Gerontol. (2016) 83:112–9. doi: 10.1016/j.exger.2016.08.005
42. Pinto CL, Botelho PB, Carneiro JA, Mota JF. Impact of creatine supplementation in combination with resistance training on lean mass in the elderly. J Cachexia Sarcopenia Muscle. (2016) 7:413–21. doi: 10.1002/jcsm.12094
43. Tarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A, Pearce E, et al. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS ONE. (2007) 2:e991. doi: 10.1371/journal.pone.0000991
44. Mazzetti SA, Kraemer WJ, Volek JS, Duncan ND, Ratamess NA, Gomez AL, et al. The influence of direct supervision of resistance training on strength performance. Med Sci Sports Exerc. (2000) 32:1175–84. doi: 10.1097/00005768-200006000-00023
45. Fyfe JJ, Bishop DJ, Stepto NK. Interference between concurrent resistance and endurance exercise: molecular bases and the role of individual training variables. Sports Med. (2014) 44:743–62. doi: 10.1007/s40279-014-0162-1
46. Gualano B, Rawson ES, Candow DG, Chilibeck PD. Creatine supplementation in the aging population: effects on skeletal muscle, bone and brain. Amino Acids. (2016) 48:1793–805. doi: 10.1007/s00726-016-2239-7
47. Lemon PW. Dietary creatine supplementation and exercise performance: why inconsistent results? Can J Appl Physiol. (2002) 27:663–81. doi: 10.1139/h02-039
48. Syrotuik DG, Bell GJ. Acute creatine monohydrate supplementation: a descriptive physiological profile of responders vs. nonresponders. J Strength Cond Res. (2004) 18:610–7. doi: 10.1519/00124278-200408000-00039
49. Moller P, Bergstrom J, Furst P, Hellstrom K. Effect of aging on energy-rich phosphagens in human skeletal muscles. Clin Sci. (1980) 58:553–5. doi: 10.1042/cs0580553
50. Forsberg AM, Nilsson E, Werneman J, Bergstrom J, Hultman E. Muscle composition in relation to age and sex. Clin Sci. (1991) 81:249–56. doi: 10.1042/cs0810249
51. Smith SA, Montain SJ, Matott RP, Zientara GP, Jolesz FA, Fielding RA. Creatine supplementation and age influence muscle metabolism during exercise. J Appl Physiol. (1998) 85:1349–56. doi: 10.1152/jappl.1998.85.4.1349
52. Solis MY, Artioli GG, Otaduy MCG, Leite CDC, Arruda W, Veiga RR, et al. Effect of age, diet, and tissue type on PCr response to creatine supplementation. J Appl Physiol. (2017) 123:407–14. doi: 10.1152/japplphysiol.00248.2017
53. Kent-Braun JA, Ng AV. Skeletal muscle oxidative capacity in young and older women and men. J Appl Physiol. (2000) 89:1072–8. doi: 10.1152/jappl.2000.89.3.1072
54. Rawson ES, Clarkson PM, Price TB, Miles MP. Differential response of muscle phosphocreatine to creatine supplementation in young and old subjects. Acta Physiol Scand. (2002) 174:57–65. doi: 10.1046/j.1365-201x.2002.00924.x
55. Burke DG, Chilibeck PD, Parise G, Candow DG, Mahoney D, Tarnopolsky M. Effect of creatine and weight training on muscle creatine and performance in vegetarians. Med Sci Sports Exerc. (2003) 35:1946–55. doi: 10.1249/01.MSS.0000093614.17517.79
56. Candow DG, Chilibeck PD. Differences in size, strength, and power of upper and lower body muscle groups in young and older men. J Gerontol A Biol Sci Med Sci. (2005) 60:148–56. doi: 10.1093/gerona/60.2.148
57. Tarnopolsky M, Parise G, Fu MH, Brose A, Parshad A, Speer O, et al. Acute and moderate-term creatine monohydrate supplementation does not affect creatine transporter mRNA or protein content in either young or elderly humans. Mol Cell Biochem. (2003) 244:159–66. doi: 10.1007/978-1-4615-0247-0_24
58. Cooper R, Naclerio F, Allgrove J, Jimenez A. Creatine supplementation with specific view to exercise/sports performance: an update. J Int Soc Sports Nutr. (2012) 9:33. doi: 10.1186/1550-2783-9-33
59. Hespel P, Op't Eijnde B, Van Leemputte M. Opposite actions of caffeine and creatine on muscle relaxation time in humans. J Appl Physiol. (2002) 92:513–8. doi: 10.1152/japplphysiol.00255.2001
60. van Leemputte M, Vandenberghe K, Hespel P. Shortening of muscle relaxation time after creatine loading. J Appl Physiol. (1999) 86:840–4. doi: 10.1152/jappl.1999.86.3.840
61. de Salles Painelli V, Alves VT, Ugrinowitsch C, Benatti FB, Artioli GG, Lancha AH, et al. Creatine supplementation prevents acute strength loss induced by concurrent exercise. Eur J Appl Physiol. (2014) 114:1749–55. doi: 10.1007/s00421-014-2903-0
62. Haff GG, Koch AJ, Potteiger JA, Kuphal KE, Magee LM, Green SB, et al. Carbohydrate supplementation attenuates muscle glycogen loss during acute bouts of resistance exercise. Int J Sport Nutr Exerc Metab. (2000) 10:326–39. doi: 10.1123/ijsnem.10.3.326
63. Roschel H, Gualano B, Marquezi M, Costa A, Lancha AH. Creatine supplementation spares muscle glycogen during high intensity intermittent exercise in rats. J Int Soc Sports Nutr. (2010) 7:6. doi: 10.1186/1550-2783-7-6
64. Xu Q, Wu Z. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem. (2000) 275:36750–7. doi: 10.1074/jbc.M005030200
65. Aguiar AF, Vechetti-Junior IJ, Alves de Souza RW, Castan EP, Milanezi-Aguiar RC, Padovani CR, et al. Myogenin, MyoD and IGF-I regulate muscle mass but not fiber-type conversion during resistance training in rats. Int J Sports Med. (2013) 34:293–301. doi: 10.1055/s-0032-1321895
66. Cornelison DD, Wold BJ. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol. (1997) 191:270–83. doi: 10.1006/dbio.1997.8721
67. Petrella JK, Kim JS, Mayhew DL, Cross JM, Bamman MM. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J Appl Physiol. (2008) 104:1736–42. doi: 10.1152/japplphysiol.01215.2007
68. Kao M, Columbus DA, Suryawan A, Steinhoff-Wagner J, Hernandez-Garcia A, Nguyen HV, et al. Enteral beta-hydroxy-beta-methylbutyrate supplementation increases protein synthesis in skeletal muscle of neonatal pigs. Am J Physiol Endocrinol Metab. (2016) 310:E1072–84. doi: 10.1152/ajpendo.00520.2015
69. Snijders T, Nederveen JP, McKay BR, Joanisse S, Verdijk LB, van Loon LJ, et al. Satellite cells in human skeletal muscle plasticity. Front Physiol. (2015) 6:283. doi: 10.3389/fphys.2015.00283
70. Kadi F, Charifi N, Denis C, Lexell J. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve. (2004) 29:120–7. doi: 10.1002/mus.10510
71. Snijders T, Verdijk LB, Smeets JS, McKay BR, Senden JM, Hartgens F, et al. The skeletal muscle satellite cell response to a single bout of resistance-type exercise is delayed with aging in men. Age. (2014) 36:9699. doi: 10.1007/s11357-014-9699-z
72. Burke DG, Candow DG, Chilibeck PD, MacNeil LG, Roy BD, Tarnopolsky MA, et al. Effect of creatine supplementation and resistance-exercise training on muscle insulin-like growth factor in young adults. Int J Sport Nutr Exerc Metab. (2008) 18:389–98. doi: 10.1123/ijsnem.18.4.389
73. Olsen S, Aagaard P, Kadi F, Tufekovic G, Verney J, Olesen JL, et al. Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training. J Physiol. (2006) 573(Pt. 2):525–34. doi: 10.1113/jphysiol.2006.107359
74. Willoughby DS, Rosene JM. Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med Sci Sports Exerc. (2003) 35:923–9. doi: 10.1249/01.MSS.0000069746.05241.F0
75. Snijders T, Bell KE, Nederveen JP, Saddler NI, Mazara N, Kumbhare DA, et al. Ingestion of a multi-ingredient supplement does not alter exercise-induced satellite cell responses in older men. J Nutr. (2018) 148:891–9. doi: 10.1093/jn/nxy063
76. Schuenke MD, Brooks NE, Hikida RS. Interactions of aging, overload, and creatine supplementation in rat plantaris muscle. J Aging Res. (2011) 2011:393416. doi: 10.4061/2011/393416
77. Zanou N, Gailly P. Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cell Mol Life Sci. (2013) 70:4117–30. doi: 10.1007/s00018-013-1330-4
78. Li M, Verdijk LB, Sakamoto K, Ely B, van Loon LJ, Musi N. Reduced AMPK-ACC and mTOR signaling in muscle from older men, and effect of resistance exercise. Mech Ageing Dev. (2012) 133:655–64. doi: 10.1016/j.mad.2012.09.001
79. Parise G, Mihic S, MacLennan D, Yarasheski KE, Tarnopolsky MA. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol. (2001) 91:1041–7. doi: 10.1152/jappl.2001.91.3.1041
80. Johnston AP, De Lisio M, Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. (2008) 33:191–9. doi: 10.1139/H07-141
81. Guidi C, Potenza L, Sestili P, Martinelli C, Guescini M, Stocchi L, et al. Differential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA. Biochim Biophys Acta. (2008) 1780:16–26. doi: 10.1016/j.bbagen.2007.09.018
82. Berneburg M, Gremmel T, Kurten V, Schroeder P, Hertel I, von Mikecz A, et al. Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences. J Invest Dermatol. (2005) 125:213–20. doi: 10.1111/j.0022-202X.2005.23806.x
83. Barbieri E, Guescini M, Calcabrini C, Vallorani L, Diaz AR, Fimognari C, et al. Creatine prevents the structural and functional damage to mitochondria in myogenic, oxidatively stressed C2C12 cells and restores their differentiation capacity. Oxid Med Cell Longev. (2016) 2016:5152029. doi: 10.1155/2016/5152029
84. Sheikholeslami-Vatani D, Faraji H. Influence of creatine supplementation on apoptosis markers after downhill running in middle-aged men: a crossover randomized, double-blind, and placebo-controlled study. Am J Phys Med Rehabil. (2018) 97:825–31. doi: 10.1097/PHM.0000000000000977
85. Bell KE, Snijders T, Zulyniak MA, Kumbhare D, Parise G, Chabowski A, et al. A multi-ingredient nutritional supplement enhances exercise training-related reductions in markers of systemic inflammation in healthy older men. Appl Physiol Nutr Metab. (2018) 43:299–302. doi: 10.1139/apnm-2017-0533
86. Derave W, Jones G, Hespel P, Harris RC. Creatine supplementation augments skeletal muscle carnosine content in senescence-accelerated mice (SAMP8). Rejuvenation Res. (2008) 11:641–7. doi: 10.1089/rej.2008.0699
87. Candow DG, Chilibeck PD. Timing of creatine or protein supplementation and resistance training in the elderly. Appl Physiol Nutr Metab. (2008) 33:184–90. doi: 10.1139/H07-139
88. Cribb PJ, Hayes A. Effects of supplement timing and resistance exercise on skeletal muscle hypertrophy. Med Sci Sports Exerc. (2006) 38:1918–25. doi: 10.1249/01.mss.0000233790.08788.3e
89. Forbes SC, Candow DG. Timing of creatine supplementation and resistance training: a brief review. J Exerc Nutr. (2018) 1:1.
90. Loenneke JP, Dankel SJ, Bell ZW, Buckner SL, Mattocks KT, Jessee MB, et al. Is muscle growth a mechanism for increasing strength? Med Hypotheses. (2019) 125:51–6. doi: 10.1016/j.mehy.2019.02.030
91. Loenneke JP, Buckner SL, Dankel SJ, Abe T. Exercise-induced changes in muscle size do not contribute to exercise-induced changes in muscle strength. Sports Med. (2019) 49:987–91. doi: 10.1007/s40279-019-01106-9
92. Schoenfeld BJ, Contreras B, Krieger J, Grgic J, Delcastillo K, Belliard R, et al. Resistance training volume enhances muscle hypertrophy but not strength in trained men. Med Sci Sports Exerc. (2019) 51:94–103. doi: 10.1249/MSS.0000000000001764
93. Bell KE, Snijders T, Zulyniak M, Kumbhare D, Parise G, Chabowski A, et al. A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: a randomized controlled trial. PLoS ONE. (2017) 12:e0181387. doi: 10.1371/journal.pone.0181387
94. O'Bryan KR, Doering TM, Morton RW, Coffey VG, Phillips SM, Cox GR. Do multi-ingredient protein supplements augment resistance training-induced gains in skeletal muscle mass and strength? A systematic review and meta-analysis of 35 trials. Br J Sports Med. (2019). doi: 10.1136/bjsports-2018-099889. [Epub ahead of print].
95. Chami J, Candow DG. Effect of creatine supplementation dosing strategies on aging muscle performance. J Nutr Health Aging. (2019) 23:281–5. doi: 10.1007/s12603-018-1148-8
96. Lobo DM, Tritto AC, da Silva LR, de Oliveira PB, Benatti FB, Roschel H, et al. Effects of long-term low-dose dietary creatine supplementation in older women. Exp Gerontol. (2015) 70:97–104. doi: 10.1016/j.exger.2015.07.012
Keywords: muscle, strength, resistance training, mechanisms, safety
Citation: Candow DG, Forbes SC, Chilibeck PD, Cornish SM, Antonio J and Kreider RB (2019) Variables Influencing the Effectiveness of Creatine Supplementation as a Therapeutic Intervention for Sarcopenia. Front. Nutr. 6:124. doi: 10.3389/fnut.2019.00124
Received: 05 April 2019; Accepted: 26 July 2019;
Published: 09 August 2019.
Edited by:
Daniel Moore, University of Toronto, CanadaReviewed by:
Hamilton Roschel, University of São Paulo, BrazilTim Snijders, Maastricht University Medical Centre, Netherlands
Michaela C. Devries, University of Waterloo, Canada
Copyright © 2019 Candow, Forbes, Chilibeck, Cornish, Antonio and Kreider. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Darren G. Candow, Darren.Candow@uregina.ca